Find Melanotan II manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

0

CEP/COS

0

JDMF

0

EU WC

0

KDMF

0

VMF

0

Listed Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

0

FDA Orange Book

0

Europe

0

Canada

0

Australia

0

South Africa

0

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Melanotan ii, 121062-08-6, Upf5cj93x7, Dtxsid90153135, L-lysinamide, n-acetyl-l-norleucyl-l-alpha-aspartyl-l-histidyl-d-phenylalanyl-l-arginyl-l-tryptophyl-, cyclic (2-7)-peptide, Refchem:925444
Molecular Formula
C50H69N15O9
Molecular Weight
1024.2  g/mol
InChI Key
JDKLPDJLXHXHNV-MFVUMRCOSA-N
FDA UNII
UPF5CJ93X7

Melanotan II
synthetic cyclic heptapeptide, an analog of alpha-melanotropin (4,10); capable of stimulating melanin synthesis & promoting rapid tanning of skin; currently in trials for use in the prevention of sunlight-induced skin cancer
1 2D Structure

Melanotan II

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(3S,6S,9R,12S,15S,23S)-15-[[(2S)-2-acetamidohexanoyl]amino]-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexazacyclotricosane-23-carboxamide
2.1.2 InChI
InChI=1S/C50H69N15O9/c1-3-4-16-36(59-29(2)66)44(69)65-41-25-42(67)55-20-11-10-18-35(43(51)68)60-47(72)39(23-31-26-57-34-17-9-8-15-33(31)34)63-45(70)37(19-12-21-56-50(52)53)61-46(71)38(22-30-13-6-5-7-14-30)62-48(73)40(64-49(41)74)24-32-27-54-28-58-32/h5-9,13-15,17,26-28,35-41,57H,3-4,10-12,16,18-25H2,1-2H3,(H2,51,68)(H,54,58)(H,55,67)(H,59,66)(H,60,72)(H,61,71)(H,62,73)(H,63,70)(H,64,74)(H,65,69)(H4,52,53,56)/t35-,36-,37-,38+,39-,40-,41-/m0/s1
2.1.3 InChI Key
JDKLPDJLXHXHNV-MFVUMRCOSA-N
2.2 Other Identifiers
2.2.1 UNII
UPF5CJ93X7
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Melanotan Ii

2. 121062-08-6

3. Upf5cj93x7

4. Dtxsid90153135

5. L-lysinamide, N-acetyl-l-norleucyl-l-alpha-aspartyl-l-histidyl-d-phenylalanyl-l-arginyl-l-tryptophyl-, Cyclic (2-7)-peptide

6. Refchem:925444

7. Dtxcid3075626

8. Mt-ii

9. Melanotan (mt)-ii

10. Melatonan

11. Melanotan Ii Acetate Salt

12. Chembl430239

13. (3s,6s,9r,12s,15s,23s)-15-[[(2s)-2-acetamidohexanoyl]amino]-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-12-(1h-imidazol-5-ylmethyl)-3-(1h-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexazacyclotricosane-23-carboxamide

14. C50h69n15o9

15. (3s,6s,9r,12s,15s,23s)-12-((1h-imidazol-5-yl)methyl)-3-((1h-indol-3-yl)methyl)-15-((s)-2-acetamidohexanamido)-9-benzyl-6-(3-guanidinopropyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexaazacyclotricosane-23-carboxamide

16. Mtii

17. Melanotanii

18. Melanotan Ii?

19. Ac-nle-cyclo[asp-his-d-phe-arg-trp-lys]-nh2

20. Unii-upf5cj93x7

21. Melanotan Ii [who-dd]

22. Ebi_340792

23. Gtpl1323

24. Orb1296657

25. Schembl1047531

26. Schembl29473785

27. Chebi:195326

28. Ex-a7394

29. Hy-p0267

30. 121062-08-6 (non-salt)

31. Bdbm50027084

32. Bdbm50184359

33. Mfcd06795842

34. Akos015994654

35. Hs-2017

36. Ncgc00167281-01

37. Da-55328

38. Fa109114

39. F93947

40. 062m086

41. Q423855

42. Acetyl-(nle4,asp5,d-phe7,lys10)-cyclo-alpha-msh (4-10) Amide

43. (3s,6s,9r,12s,15s,23s)-12-((1h-imidazol-5-yl)methyl)-3-((1h-indol-3-yl)methyl)-15-((s)-2-acetamidohexanamido)-9-benzyl-6-(3-((diaminomethylene)amino)propyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexaazacyclotricosane-23-carboxamide

44. (3s,6s,9r,12s,15s,23s)-15-((s)-2-acetylamino-hexanoylamino)-9-benzyl-6-(3-guanidino-propyl)-12-(3h-imidazol-4-ylmethyl)-3-(1h-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18hexaaza-cyclotricosane-23-carboxylic Acid Amide

45. (3s,6s,9r,12s,15s,23s)-15-[(n-acetyl-l-norleucyl)amino]-9-benzyl-6-{3-[(diaminomethylidene)amino]propyl}-12-[(1h-imidazol-5-yl)methyl]-3-[(1h-indol-3-yl)methyl]-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexaazacyclotricosane-23-carboxamide

46. (3s,6s,9r,12s,15s,23s)-15-[[(2s)-2-acetamidohexanoyl]amino]-9-benzyl-6-(3-guanidinopropyl)-12-(1h-imidazol-5-ylmethyl)-3-(1h-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexazacyclotricosane-23-carboxamide

47. (3s,6s,9r,12s,15s,23s)-9-benzyl-6-{3-[(diaminomethylidene)amino]propyl}-15-[(2s)-2-acetamidohexanamido]-12-(1h-imidazol-5-ylmethyl)-3-(1h-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexaazacyclotricosane-23-carboxamide

48. L-lysinamide, N-acetyl-l-norleucyl-l-.alpha.-aspartyl-l-histidyl-d-phenylalanyl-l-arginyl-l-tryptophyl-, Cyclic (2->7)-peptide

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 1024.2 g/mol
Molecular Formula C50H69N15O9
XLogP30
Hydrogen Bond Donor Count13
Hydrogen Bond Acceptor Count11
Rotatable Bond Count17
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area385
Heavy Atom Count74
Formal Charge0
Complexity1950
Isotope Atom Count0
Defined Atom Stereocenter Count7
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

ABOUT THIS PAGE

Looking for 121062-08-6 / Melanotan II API manufacturers, exporters & distributors?

Melanotan II manufacturers, exporters & distributors 1

82

PharmaCompass offers a list of Melanotan II API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Melanotan II manufacturer or Melanotan II supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Melanotan II manufacturer or Melanotan II supplier.

API | Excipient name

Melanotan II

Synonyms

121062-08-6, Upf5cj93x7, Dtxsid90153135, L-lysinamide, n-acetyl-l-norleucyl-l-alpha-aspartyl-l-histidyl-d-phenylalanyl-l-arginyl-l-tryptophyl-, cyclic (2-7)-peptide, Refchem:925444, Dtxcid3075626

Cas Number

121062-08-6

Unique Ingredient Identifier (UNII)

UPF5CJ93X7

About Melanotan II

synthetic cyclic heptapeptide, an analog of alpha-melanotropin (4,10); capable of stimulating melanin synthesis & promoting rapid tanning of skin; currently in trials for use in the prevention of sunlight-induced skin cancer

Melanotan II Manufacturers

A Melanotan II manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Melanotan II, including repackagers and relabelers. The FDA regulates Melanotan II manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Melanotan II API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Melanotan II Suppliers

A Melanotan II supplier is an individual or a company that provides Melanotan II active pharmaceutical ingredient (API) or Melanotan II finished formulations upon request. The Melanotan II suppliers may include Melanotan II API manufacturers, exporters, distributors and traders.

click here to find a list of Melanotan II suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Melanotan II NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Melanotan II as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Melanotan II API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Melanotan II as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Melanotan II and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Melanotan II NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Melanotan II suppliers with NDC on PharmaCompass.

Melanotan II GMP

Melanotan II Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Melanotan II GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Melanotan II GMP manufacturer or Melanotan II GMP API supplier for your needs.

Melanotan II CoA

A Melanotan II CoA (Certificate of Analysis) is a formal document that attests to Melanotan II's compliance with Melanotan II specifications and serves as a tool for batch-level quality control.

Melanotan II CoA mostly includes findings from lab analyses of a specific batch. For each Melanotan II CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Melanotan II may be tested according to a variety of international standards, such as European Pharmacopoeia (Melanotan II EP), Melanotan II JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Melanotan II USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty